Aobo Zhuang
Overview
Explore the profile of Aobo Zhuang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng J, Lin Z, Li X, Miao F, Maimaitiming T, Ma Y, et al.
ACS Appl Mater Interfaces
. 2025 Feb;
17(10):14859-14872.
PMID: 40014576
Embolotherapy is an effective antitumor method, which essentially blocks the oxygen supply and induces hypoxia to treat tumors; however, traditional practices demand high expertise and harbor risks of complications. This...
2.
Xie F, Niu Y, Chen X, Kong X, Yan G, Zhuang A, et al.
J Pharm Anal
. 2025 Feb;
15(1):101068.
PMID: 39902457
Ursodeoxycholic acid (UDCA) is a naturally occurring, low-toxicity, and hydrophilic bile acid (BA) in the human body that is converted by intestinal flora using primary BA. Solute carrier family 7...
3.
Zhou X, Zhuang A, Li X, Xi Z, Cheng Y, Yan G, et al.
Front Oncol
. 2024 Nov;
14:1431920.
PMID: 39525625
Background: Difficulty in achieving complete resection leads to a poor prognosis for retroperitoneal soft tissue sarcoma, hence emphasizing the significance of adjuvant treatment. The benefit of preoperative radiotherapy for retroperitoneal...
4.
Cheng Y, Xi Z, Zhuang A, Li X, Wang Y, Yan G, et al.
Medicine (Baltimore)
. 2024 Aug;
103(35):e39284.
PMID: 39213215
Rationale: Biliary system anomalies, such as duplicated gallbladders, are rare congenital conditions that present significant diagnostic challenges. Dr. Boyden's classification system, especially the H-type anomaly, offers vital insight into these...
5.
Xi Z, Zhuang A, Li X, Ming T, Cheng Y, Zhang C, et al.
Heliyon
. 2024 Aug;
10(15):e34878.
PMID: 39157358
Background: Liposarcoma is a malignant tumor that originates from adipose tissue and can occur in any part of the body. There is currently no clear conclusion on whether there are...
6.
Xie F, Niu Y, Lian L, Wang Y, Zhuang A, Yan G, et al.
Front Med
. 2023 Dec;
18(2):375-393.
PMID: 38157196
Retroperitoneal liposarcoma (RLPS) is the main subtype of retroperitoneal soft sarcoma (RSTS) and has a poor prognosis and few treatment options, except for surgery. The proteomic and metabolic profiles of...
7.
Zheng J, Zhuang A, Xia X, Miao F, Wang Z, Kong X, et al.
Discov Oncol
. 2023 Nov;
14(1):197.
PMID: 37910291
Background: Primary retroperitoneal sarcoma (RPS) comprises over 70 histologic subtypes, yet there are limited studies that have developed prognostic nomograms for RPS patients to predict overall survival (OS) and cancer-specific...
8.
Zheng J, Miao F, Wang Z, Ma Y, Lin Z, Chen Y, et al.
Life Sci
. 2023 Jun;
327:121832.
PMID: 37276911
Background: The murine double minute 2 (MDM2) gene is a crucial factor in the development and progression of various cancer types. Multiple rigorous scientific studies have consistently shown its involvement...
9.
Zhuang A, Chen Y, Wang J, Xu J, Tong H, Zhou Y, et al.
J Clin Transl Res
. 2023 May;
9(2):101-109.
PMID: 37179789
Background: Although surgery plays a key role in the treatment of the primary retroperitoneal sarcoma (RPS), there remain few reports on the primary multifocal RPS. Aims: This study aimed to...
10.
Zhuang A, Zhuang A, Chen Y, Qin Z, Zhu D, Ren L, et al.
Elife
. 2023 May;
12.
PMID: 37158593
The presence of lymph node metastasis (LNM) affects treatment strategy decisions in T1NxM0 colorectal cancer (CRC), but the currently used clinicopathological-based risk stratification cannot predict LNM accurately. In this study,...